APA
Alda J. A., Soutullo C., Ramos-Quiroga J. A., Quintero J., Hervás A., Hernández-Otero I., Sans-Fitó A., Cardo-Jalón E. C., Fernández-Jaén A., Fernández-Pérez M., Hidalgo-Vicario M. I., Eddy-Ives L. S. & Sánchez J. (20161213). Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD). : Actas espanolas de psiquiatria.
Chicago
Alda José A, Soutullo César, Ramos-Quiroga Josep A, Quintero Javier, Hervás Amaia, Hernández-Otero Isabel, Sans-Fitó Anna, Cardo-Jalón Esther Cardo-Jalón, Fernández-Jaén Alberto, Fernández-Pérez Maximino, Hidalgo-Vicario M Inés, Eddy-Ives Lefa S and Sánchez Javier. 20161213. Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD). : Actas espanolas de psiquiatria.
Harvard
Alda J. A., Soutullo C., Ramos-Quiroga J. A., Quintero J., Hervás A., Hernández-Otero I., Sans-Fitó A., Cardo-Jalón E. C., Fernández-Jaén A., Fernández-Pérez M., Hidalgo-Vicario M. I., Eddy-Ives L. S. and Sánchez J. (20161213). Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD). : Actas espanolas de psiquiatria.
MLA
Alda José A, Soutullo César, Ramos-Quiroga Josep A, Quintero Javier, Hervás Amaia, Hernández-Otero Isabel, Sans-Fitó Anna, Cardo-Jalón Esther Cardo-Jalón, Fernández-Jaén Alberto, Fernández-Pérez Maximino, Hidalgo-Vicario M Inés, Eddy-Ives Lefa S and Sánchez Javier. Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD). : Actas espanolas de psiquiatria. 20161213.